Cargando…
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
Autores principales: | Kimmerling, Robert J., Stevens, Mark M., Olcum, Selim, Minnah, Anthony, Vacha, Madeleine, LaBella, Rachel, Ferri, Matthew, Wasserman, Steven C., Fujii, Juanita, Shaheen, Zayna, Sundaresan, Srividya, Ribadeneyra, Drew, Jayabalan, David S., Agte, Sarita, Aleman, Adolfo, Criscitiello, Joseph A., Niesvizky, Ruben, Luskin, Marlise R., Parekh, Samir, Rosenbaum, Cara A., Tamrazi, Anobel, Reid, Clifford A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823002/ https://www.ncbi.nlm.nih.gov/pubmed/36609595 http://dx.doi.org/10.1038/s42003-022-04376-8 |
Ejemplares similares
-
A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
por: Kimmerling, Robert J., et al.
Publicado: (2022) -
Endovascular image-guided sampling of tumor-draining veins provides an enriched source of oncological biomarkers
por: Tamrazi, Anobel, et al.
Publicado: (2023) -
The Bacillus Agnostic
Publicado: (1911) -
Agnostic Tendency in Doctors
Publicado: (1885) -
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance
por: Mejia Saldarriaga, Mateo, et al.
Publicado: (2022)